Notícias

Retail Sales cool as expected, Jobless Claims improve and Philly Fed shoots up 4x estimates.

UnitedHealth Group (NYSE:UNH) reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that busin

Magellan Investment Partners, an Australian investment management company, released its second-quarter 2026 investor letter for “Magellan Global Opportunities Fund”. A copy of the letter can be downloaded here. The Fund invests in companies with sustainable competitive advantages that generate returns exceeding their cost of capital over time. In Q2, the global stock market rose 13.8%, […]

While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.

UnitedHealth (UNH) raised its full-year earnings outlook on Thursday as the health insurance giant r

The core narrative surrounding UnitedHealth Group (UNH) is dominated by its successful margin recovery, yet the underlying data reveal a shift from a growth compounder to a vulnerable margin defender. The defining insight is not the massive bottom-line beat of a $6.38 adjusted earnings per share against a $4.94 consensus estimate. Rather, it is the deliberate contraction of the core membership base to support margins in the face of significant regulatory headwinds.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3%, and the actively t

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

Investing.com -- U.S. stock index futures were mixed on Thursday as investors weighed lingering Middle East tensions, and focused on corporate earnings and further signs that U.S. inflationary pressures are easing.

The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.

AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.

Stock Market Today: Tech futures tumbled Thursday as Sandisk and SK Hynix plunged. TSMC sold off on earnings.

UnitedHealth Stock Rallies as Profit, Revenue Top Wall Street Expectations

A lower medical cost ratio lifted operating earnings to $8 billion, up from $5.2 billion a year ago

US equity markets were mostly tracking in the red before the opening bell Thursday as traders await

The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share

Semiconductor stocks are dragging Nasdaq futures lower, while UnitedHealth stock jumped 4% after topping earnings expectations

Health insurance company UnitedHealth (NYSE:UNH) announced better-than-expected revenue in Q2 CY2026, but sales were flat year on year at $112 billion. Its non-GAAP profit of $6.38 per share was 30.6% above analysts’ consensus estimates.

UnitedHealth Group is back in focus as analysts adjust their price targets, with updated fair value estimates now set at US$424.23 compared with the prior US$411.31. Behind these tweaks, recent research has weighed steadier views on Medicare Advantage, Medicaid and ACA exchanges against mixed opinions on medical cost pressures and the durability of current trends. As you read on, you will see how these shifting signals feed into the evolving analyst narrative and what to watch next in...

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.

Investing.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.

The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.

Investors parsed signals on the AI build-out, consumer spending, geopolitical uncertainty, and more in a packed Thursday session.

Investors were set to parse signals on the AI build-out, consumer spending, geopolitical uncertainty, and more in a packed Thursday session.

By Amina Niasse NEW YORK, July 16 (Reuters) - UnitedHealth Group raised on Thursday its 2026 profit forecast as the company tightened spending on medical costs and improved operating income in its

↘️ Dell Technologies (DELL): The stock extended its decline in premarket trading following a double-digit drop yesterday, driven by mounting fears of an industry-wide AI overbuild. ↘️ Taiwan Semiconductor Manufacturing (TSM): The chip maker’s U.

Stocks were on track to slide Thursday as the artificial-intelligence trade lost some momentum, with investors opting to take profit even though the broader macroeconomic environment is looking good for the market. Nasdaq 100 futures dropped 0.6%. Investors are questioning how long the AI boom will last–but still finding plenty of places to put their money in the market.

Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan.

UnitedHealth Group’s stock fell hard in 2025. When the healthcare insurer reports second-quarter results Thursday, the company’s 2026 bounceback has investors eager for confirmation that medical spending trends are in hand. UnitedHealth has notched a series of wins heading into earnings season.